The N-terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition

Synthesis, Conformational Analysis, and Binding Studies

Pasquale Palladino, Luigi Portella, Giovanni Colonna, Raffaele Raucci, Gabriella Saviano, Filomena Rossi, Maria Napolitano, Stefania Scala, Giuseppe Castello, Susan Costantini

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The chemokines and their receptors play a key role in immune and inflammatory responses by promoting recruitment and activation of different subpopulations of leukocytes. The membrane receptor CXCR3 binds three chemokines, CXCL9, CXCL10, and CXCL11, and its involvement is recognized in many inflammatory diseases and cancers. Therefore, the inhibition of CXCR3 pathway through interactions with three ligands was indicated as putative therapeutic target for the treatment of these diseases, and some inhibitory compounds have already been described in the literature. Recently, we studied the interaction between CXCR3 and its three natural ligands and showed that three CXCR3 ligands bound the receptor mainly by their N-terminal regions using aromatic and electrostatic interactions, and, in particular, CXCL11 had the highest affinity for CXCR3. In light of these results, we focused our attention on what structural region(s) of CXCL11 interacted with CXCR3 and what were the structural features. Therefore, we have synthesized three peptides, corresponding to the N-terminal region of CXCL11, but with different aromatic amino acids, analyzed their conformations by circular dichroism, NMR, and molecular dynamics simulations, simulated their complexes with CXCR3 by docking methods, and validated these data by in vitro studies. The results showed that two peptides were able to bind CXCR3 and to mimic the molecular recognition of CXCL11 and demonstrated that N-terminal region of CXCL11 can be used as template and starting point to obtain new molecules by de novo design approaches.

Original languageEnglish
Pages (from-to)254-265
Number of pages12
JournalChemical Biology and Drug Design
Volume80
Issue number2
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Molecular recognition
Ligands
Chemokine CXCL11
Chemokine CXCL9
CXCR3 Receptors
Chemokine CXCL10
Aromatic Amino Acids
Peptides
Chemokine Receptors
Molecular Dynamics Simulation
Circular Dichroism
Coulomb interactions
Static Electricity
Conformations
Molecular dynamics
Leukocytes
Chemical activation
Nuclear magnetic resonance
Membranes
Molecules

Keywords

  • Antagonists
  • Cancer
  • CXC chemokines
  • CXCR3
  • Inflammation
  • Molecular docking
  • Molecular dynamics
  • Molecular recognition
  • NMR

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

The N-terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition : Synthesis, Conformational Analysis, and Binding Studies. / Palladino, Pasquale; Portella, Luigi; Colonna, Giovanni; Raucci, Raffaele; Saviano, Gabriella; Rossi, Filomena; Napolitano, Maria; Scala, Stefania; Castello, Giuseppe; Costantini, Susan.

In: Chemical Biology and Drug Design, Vol. 80, No. 2, 08.2012, p. 254-265.

Research output: Contribution to journalArticle

@article{491e49fa65014de4aee3354a2140a5d5,
title = "The N-terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition: Synthesis, Conformational Analysis, and Binding Studies",
abstract = "The chemokines and their receptors play a key role in immune and inflammatory responses by promoting recruitment and activation of different subpopulations of leukocytes. The membrane receptor CXCR3 binds three chemokines, CXCL9, CXCL10, and CXCL11, and its involvement is recognized in many inflammatory diseases and cancers. Therefore, the inhibition of CXCR3 pathway through interactions with three ligands was indicated as putative therapeutic target for the treatment of these diseases, and some inhibitory compounds have already been described in the literature. Recently, we studied the interaction between CXCR3 and its three natural ligands and showed that three CXCR3 ligands bound the receptor mainly by their N-terminal regions using aromatic and electrostatic interactions, and, in particular, CXCL11 had the highest affinity for CXCR3. In light of these results, we focused our attention on what structural region(s) of CXCL11 interacted with CXCR3 and what were the structural features. Therefore, we have synthesized three peptides, corresponding to the N-terminal region of CXCL11, but with different aromatic amino acids, analyzed their conformations by circular dichroism, NMR, and molecular dynamics simulations, simulated their complexes with CXCR3 by docking methods, and validated these data by in vitro studies. The results showed that two peptides were able to bind CXCR3 and to mimic the molecular recognition of CXCL11 and demonstrated that N-terminal region of CXCL11 can be used as template and starting point to obtain new molecules by de novo design approaches.",
keywords = "Antagonists, Cancer, CXC chemokines, CXCR3, Inflammation, Molecular docking, Molecular dynamics, Molecular recognition, NMR",
author = "Pasquale Palladino and Luigi Portella and Giovanni Colonna and Raffaele Raucci and Gabriella Saviano and Filomena Rossi and Maria Napolitano and Stefania Scala and Giuseppe Castello and Susan Costantini",
year = "2012",
month = "8",
doi = "10.1111/j.1747-0285.2012.01397.x",
language = "English",
volume = "80",
pages = "254--265",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "2",

}

TY - JOUR

T1 - The N-terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition

T2 - Synthesis, Conformational Analysis, and Binding Studies

AU - Palladino, Pasquale

AU - Portella, Luigi

AU - Colonna, Giovanni

AU - Raucci, Raffaele

AU - Saviano, Gabriella

AU - Rossi, Filomena

AU - Napolitano, Maria

AU - Scala, Stefania

AU - Castello, Giuseppe

AU - Costantini, Susan

PY - 2012/8

Y1 - 2012/8

N2 - The chemokines and their receptors play a key role in immune and inflammatory responses by promoting recruitment and activation of different subpopulations of leukocytes. The membrane receptor CXCR3 binds three chemokines, CXCL9, CXCL10, and CXCL11, and its involvement is recognized in many inflammatory diseases and cancers. Therefore, the inhibition of CXCR3 pathway through interactions with three ligands was indicated as putative therapeutic target for the treatment of these diseases, and some inhibitory compounds have already been described in the literature. Recently, we studied the interaction between CXCR3 and its three natural ligands and showed that three CXCR3 ligands bound the receptor mainly by their N-terminal regions using aromatic and electrostatic interactions, and, in particular, CXCL11 had the highest affinity for CXCR3. In light of these results, we focused our attention on what structural region(s) of CXCL11 interacted with CXCR3 and what were the structural features. Therefore, we have synthesized three peptides, corresponding to the N-terminal region of CXCL11, but with different aromatic amino acids, analyzed their conformations by circular dichroism, NMR, and molecular dynamics simulations, simulated their complexes with CXCR3 by docking methods, and validated these data by in vitro studies. The results showed that two peptides were able to bind CXCR3 and to mimic the molecular recognition of CXCL11 and demonstrated that N-terminal region of CXCL11 can be used as template and starting point to obtain new molecules by de novo design approaches.

AB - The chemokines and their receptors play a key role in immune and inflammatory responses by promoting recruitment and activation of different subpopulations of leukocytes. The membrane receptor CXCR3 binds three chemokines, CXCL9, CXCL10, and CXCL11, and its involvement is recognized in many inflammatory diseases and cancers. Therefore, the inhibition of CXCR3 pathway through interactions with three ligands was indicated as putative therapeutic target for the treatment of these diseases, and some inhibitory compounds have already been described in the literature. Recently, we studied the interaction between CXCR3 and its three natural ligands and showed that three CXCR3 ligands bound the receptor mainly by their N-terminal regions using aromatic and electrostatic interactions, and, in particular, CXCL11 had the highest affinity for CXCR3. In light of these results, we focused our attention on what structural region(s) of CXCL11 interacted with CXCR3 and what were the structural features. Therefore, we have synthesized three peptides, corresponding to the N-terminal region of CXCL11, but with different aromatic amino acids, analyzed their conformations by circular dichroism, NMR, and molecular dynamics simulations, simulated their complexes with CXCR3 by docking methods, and validated these data by in vitro studies. The results showed that two peptides were able to bind CXCR3 and to mimic the molecular recognition of CXCL11 and demonstrated that N-terminal region of CXCL11 can be used as template and starting point to obtain new molecules by de novo design approaches.

KW - Antagonists

KW - Cancer

KW - CXC chemokines

KW - CXCR3

KW - Inflammation

KW - Molecular docking

KW - Molecular dynamics

KW - Molecular recognition

KW - NMR

UR - http://www.scopus.com/inward/record.url?scp=84864019145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864019145&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2012.01397.x

DO - 10.1111/j.1747-0285.2012.01397.x

M3 - Article

VL - 80

SP - 254

EP - 265

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 2

ER -